By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > The perils of impenetrable gibberish
News

The perils of impenetrable gibberish

News Room
Last updated: 2023/08/13 at 2:34 AM
By News Room
Share
6 Min Read
SHARE

Receive free Work & Careers updates

We’ll send you a myFT Daily Digest email rounding up the latest Work & Careers news every morning.

In London this month, it is possible to pay up to £195 for a ticket to a two and a half-hour play about the importance of washing your hands.

It is called Dr Semmelweis after Ignaz Semmelweis, a prickly Hungarian doctor who died without being recognised for groundbreaking discoveries he made in the 1800s about disinfection.

I went last week, for considerably less than £195, mostly because the riveting Mark Rylance plays Semmelweis, but also after confirming that the two-and-a-half-hour running time included the interval.

I’m glad I did because the Semmelweis story turns out to confirm a long-held view that rotten writing at work is not just irritating but potentially dangerous.

He was surrounded by baffling dangers when he worked in the labour wards of a Vienna hospital at a time when so-called childbed fever was ravaging maternity departments across Europe.

There were two separate maternity clinics in his hospital. Babies were delivered by doctors in one and by midwives in the other.

Death rates were much higher in the clinic with the doctors, who typically went to the labour wards after doing autopsies without washing their hands. Thinking “cadaverous particles” might have stayed on those hands, Semmelweis devised a policy requiring everyone to scrub their hands in chlorine before entering the labour wards and bingo: death rates in the doctors’ clinic plunged.

Alas, the idea did not catch on. Some of Semmelweis’s colleagues disliked the suggestion they were causing their patients’ deaths. Others disliked the undiplomatic and difficult Semmelweis himself. He left Vienna and led an increasingly troubled life, dying in a mental asylum at the age of 47.

Rylance brings his story to life on stage with predictable brilliance. But the play does not dwell on one part of Semmelweis’s downfall that I came across later. When he finally got around to writing a book outlining his research, it was a clunker. 

“It was criticised for poor language and unprofessional writing style,” says one medical journal article on Semmelweis. “Long, repetitive and at times almost impenetrable,” reports another. The only English language version I could find online confirms that, even by 19th century standards, snappy it was not.

Still, Semmelweis was an embittered outcast with serious mental health problems. There is no excuse for the guff emitted by some of our most storied corporate titans today, especially when they are announcing financial results.

“I remain fully confident that continued execution will enable us to deliver on our through-the-cycle return targets,” David Solomon, Goldman Sachs chief executive, told investors a few weeks ago.

He was comprehensively outdone days later when Jim Fitterling, chief executive of the Dow Chemical group, said: “We proactively navigated the challenging near-term macro environment by implementing our targeted cost savings actions while capitalising on our advantaged feedstock position and participation in attractive end-markets.”

The legal profession is another reliable source of gibberish, so it was a delight to see it produce a court document this month that reads like a pacy thriller.

I speak of the latest indictment against Donald Trump, which accuses the former president of trying to overturn the results of the 2020 presidential election. 

This is a story of death threats, violence and frantic plotting, where a string of little-known heroes stand up to extraordinary efforts to pressure them to break the law. 

At the centre is the smouldering figure of Trump, remorselessly seeking ways to stay in power, to the bewilderment of many aides.

“It’s tough to own any of this when it’s all just conspiracy shit beamed down from the mother ship,” writes one senior Trump campaign adviser.

“It’s a crazy play,” writes another.

Could any of this make a difference to the outcome of the trial, or Trump’s hopes of winning next year’s US presidential election?

It is impossible to say. Bad writing alone did not bring down Ignaz Semmelweis and a highly readable legal case may not dent Trump. 

I like to think the compelling way this case is told might stay in the minds of swing voters come November next year. But either way, it is a reminder of what a film Trump’s legal battles could eventually make, though even Mark Rylance might struggle to make a character this fantastic seem real.

[email protected]

Read the full article here

News Room August 13, 2023 August 13, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
How AI Is Changing Shopping

Watch full video on YouTube

Nvidia Q3 earnings: Why the setup for Nvidia is looking very good ‘from multiple angles’

Watch full video on YouTube

Meridian Corporation Justifies Greater Upside From Here (NASDAQ:MRBK)

This article was written byFollowDaniel is an avid and active professional investor.…

What economists got wrong in 2025

Welcome back. As this is my last edition before the new year,…

Inside America’s Race To Build The Next Generation Of AI Chips

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

News

Meridian Corporation Justifies Greater Upside From Here (NASDAQ:MRBK)

By News Room
News

What economists got wrong in 2025

By News Room
News

Quanex Building Products Corporation (NX) Q4 2025 Earnings Call Transcript

By News Room
News

Europe’s rocky relations with Donald Trump

By News Room
News

Crypto founder Do Kwon sentenced to 15 years in prison

By News Room
News

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data – Slideshow (NASDAQ:CRBP) 2025-12-11

By News Room
News

Disney to invest $1bn into OpenAI

By News Room
News

Freedom for Venezuela coming ‘soon’, says opposition leader

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?